Sensitivity to further endocrine therapy is retained following progression on first-line fulvestrant. (Q46573379)
Jump to navigation
Jump to search
scientific article published in July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sensitivity to further endocrine therapy is retained following progression on first-line fulvestrant. |
scientific article published in July 2005 |
Statements
Sensitivity to further endocrine therapy is retained following progression on first-line fulvestrant (English)
J F R Robertson
V A Gorbunova
T Watanabe